In fact, PTEN expression is diminished in 19% of all breast cancers, and in over 50% of TNBCs (RNA-seq z-score cutoff for downregulation < −1)30,31, where PTEN transcript level rather than mutation or posttranslational modification is the primary determinant of PTEN protein expression28. The gene discussed is PTEN; the disease is breast cancer.